Utama › Kanser Prostat › California › San Francisco
Kajian klinikal Kanser Prostat di San Francisco, CA
45 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar San Francisco (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
Mengambil pesertaKajian pemerhatian
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaFasa 3
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Mengambil peserta
- University of California San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Kaiser Permanente-San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Mengambil pesertaFasa 1
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaKajian pemerhatian
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Mengambil pesertaFasa 3
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Mengambil pesertaFasa 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mengambil pesertaFasa 1/2
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- University of California San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
Mengambil pesertaFasa 1
- University of California, San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Mengambil pesertaFasa 1
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Mengambil peserta
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Mengambil pesertaFasa awal 1
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Mengambil peserta
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Mengambil pesertaFasa 3
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
Mengambil pesertaFasa 1/2
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Mengambil peserta
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Mengambil peserta
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
- Dallas, TX36 kajian
Kajian lain di San Francisco
- Kanser Payudara43 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)35 kajian
- Kegagalan Jantung29 kajian
- Kanser Metastatik28 kajian
- Kanser Paru-paru23 kajian
- Melanoma22 kajian
- Kanser Pankreas20 kajian
- Kanser Ovari19 kajian
- Kanser Kolorektal18 kajian
- Penyakit Kardiovaskular18 kajian
- Glioblastoma17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.